Company Filing History:
Years Active: 2007-2009
Title: Edwige Leclere: Innovator in Prion Detection
Introduction
Edwige Leclere is a prominent inventor based in Lyons, France. She has made significant contributions to the field of prion detection, holding 2 patents that showcase her innovative approaches. Her work is crucial in understanding and detecting prion diseases, which pose serious health risks to both humans and animals.
Latest Patents
Leclere's latest patents include a method for detecting PrP using at least one positive charge and/or at least one glycosidic bond and a ligand other than a protein ligand. This invention relates to a method for detecting PrP in biological samples that may contain the prion protein. The method is characterized by the use of a molecule containing at least one positive charge and/or at least one osidic bond, along with a ligand selected from macrocyclic ligands and glycosaminoglycans. Another notable patent is a process for detecting PrP using a macrocyclic adjuvant ligand. This process involves adding a macrocyclic adjuvant ligand to a biological sample capable of containing PrP, followed by a reaction with an anti-PrP antibody to detect the presence of PrP.
Career Highlights
Throughout her career, Edwige Leclere has worked with esteemed organizations such as the Centre National de la Recherche Scientifique and bioMérieux, Inc. Her experience in these institutions has allowed her to develop and refine her innovative methods for prion detection.
Collaborations
Leclere has collaborated with notable colleagues, including Anthony William Coleman and Eric Da Silva. These partnerships have contributed to her research and advancements in the field.
Conclusion
Edwige Leclere's contributions to prion detection through her innovative patents highlight her role as a leading inventor in this critical area of research. Her work continues to impact the scientific community and enhance our understanding of prion diseases.